Articles & Issues

Cover Image

Abstracts of WFN XIX World Congress on Parkinson's Disease and Related Disorders

11 December 2011 - 14 December 2011

Search Within This Issue

923 Articles:

Article Title Author(s) Pages
Editorial Board

i
Committees

iv
Monday, 12 December 2011
Invited Lectures
Article Title Author(s) Pages
1.1.1 AUTOSOMAL DOMINANT PARKINSONISM

N. Hattori S1
1.1.2 AUTOSOMAL RECESSIVE PARKINSONISM

V. Bonifati S1
1.1.3 AUTOSOMAL DOMINANT PARKINSON'S DISEASE

Z.K. Wszolek S1
1.1.4 AUTOSOMAL RECESSIVE PARKINSON'S DISEASE

R.M. Wu S1
1.2.1 VACCINES IN PARKINSON'S DISEASE

A. Schneeberger S2
1.2.2 USING STEM CELLS AND IPS CELLS TO DISCOVER NEW TREATMENTS FOR PARKINSON'S DISEASE

O. Cooper, P. Hallett, O. Isacson S2
1.2.3 MISFOLDED α-SYNUCLEIN AND NEUROINFLAMMATION AS THERAPEUTIC TARGETS FOR PARKINSON'S DISEASE

K.A. Maguire-Zeiss S2
1.2.4 NEW TARGETS FOR DBS

A.L. Benabid, N. Torres, S. Chabardes S2
1.3.1 SYNUCLEINOPATHIES FROM BENCH TO BEDSIDE (PD, MSA, ADHD, RLS)

A. Puschmann, R. Bhidayasiri, W.J. Weiner S2-S3
1.5.1 GENETICS

B. Tang S3
1.5.2 ERK PATHWAY IS INVOLVED IN SNCA INDUCED MITOCHONDRIAL DYNAMIC DISORDERS BY REGULATING DLP1

J. Liu, Y.-X. Gui, S. Chen S3
1.5.3 METABOLIC NETWORKING IN CHINESE PATIENTS WITH PARKINSON'S DISEASE IN VARIOUS HOEHN & YAHR STAGES

J. Wang, C. Zuo, P. Wu, H. Zhang, Y. Guan, J. Wu, Z. Ding, Y. Jiang et al. S3
1.5.4 BIOMARKERS FOR EARLY DIAGNOSIS OF PD

P. Xu S3-S4
1.7.1 NEUROPATHOLOGY IN THE PREMOTOR STAGES AND SUBTYPES OF PARKINSON'S DISEASE

W.D.J. van de Berg, A.A. Dijkstra, D.H. Hebb, A.J.M. Rozemuller S4
1.7.2 DIAGNOSIS OF PD

D.J. Brooks S4
1.7.3 QUALITY TREATMENT OF PARKINSON'S DISEASE

R.J. Uitti S4
1.7.4 UPCOMING TREATMENTS IN PARKINSON'S DISEASE, INCLUDING GENE THERAPY

R. Rodnitzky S4
1.8.2 THE ROLE OF DOPAMINE AGONISTS IN THE TREATMENT OF EARLY AND ADVANCED PD

A. Schapira S5
1.8.3 NON MOTOR SYMPTOMS IN PD: IMPACT ON QUALITY OF LIFE AND MEDICAL TREATMENT

P. Barone S5
1.8.4 ONCE DAILY TREATMENTS IN PD: AN UPDATE

N. Hattori S5
1.10.1 WHAT ABOUT BRAAK

I. Alafuzoff S5
1.11.1 MILD COGNITIVE IMPAIRMENT ASSOCIATED WITH UNDERLYING ALZHEIMER'S DISEASE VERSUS LEWY BODY DISEASE

B. Boeve S5
1.12.1 PARKINSON'S DISEASE: MOLECULAR RISK FACTORS

E. Grünblatt S5
1.12.2 ADVANCES IN CSF BIOMARKERS OF PARKINSON'S DISEASE

P. LeWitt S5-S6
1.12.3 NEURONAL VULNERABILITY IN PARKINSON'S DISEASE

K.L. Double S6
1.12.4 NEUROIMAGING IN PARKINSON'S DISEASE

A.J. Stoessl S6
1.13.1 THE GWAS PERSPECTIVE AND BEYOND

T. Gasser S6
1.13.2 SNP VARIANTS IN PARKINSON'S DISEASE

E.K. Tan S6
1.13.3 ROLE OF MENDELIAN GENES IN SPORADIC PD

A. Brice S6-S7
1.13.4 MOLECULAR PATHWAYS IN SPORADIC PD

E.M. Valente S7
1.14.1 MOOD DISORDERS

L. Tan S7
1.14.2 COGNITIVE DEFICITS IN PARKINSON'S DISEASE: VARIABILITY, EVOLUTION, AND EFFECT OF DOPAMINERGIC MEDIATION

O. Monchi S7
1.14.3 DOPAMINE DEPENDENCY AND PUNDING

J.M. Rabey S7-S8
1.14.4 IMPULSE CONTROL DISORDERS

E. Tolosa S8
1.15.1 TAUOPATHIES: FROM BENCH TO BEDSIDE

Y. Pijnenburg, D. Waldvogel S8
1.17.1 CHOREA AND RELATED DISORDER

B. Zhang S8
1.17.2 THE DIAGNOSIS AND TREATMENT OF DYSTONIA

W.L. Wanglijuan S8
1.17.3 MULTIPLE SYSTEM ATROPHY

M. Shao S8-S9
1.19.2 PD IN EVOLUTION: PRODROME TO DEGENERATION

A. Schapira S9
1.19.3 THE CONTRIBUTION OF DOPAMINERGIC AND NON-DOPAMINERGIC PATHWAYS TO THE PATHOPHYSIOLOGY OF PD

E.C. Wolters S9-S10
1.19.4 STEM CELLS AND GENE THERAPY IN PD: FUTURE DIRECTIONS

J.H. Kordower S10
Posters
Article Title Author(s) Pages
1.001 PARKINSON'S DISEASE IN HISTORY

A. Kaadan S10
1.002 MEDICO LEGAL ASPECTS OF PARKINSON'S DISEASE

R.Y.P. Babu, K. Kishan, S. Raghavendra S10
1.003 FACILITATING CLINICAL RESEARCH: THE NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS (NINDS) AND STROKE PARKINSON'S DISEASE COMMON DATA ELEMENTS PROJECT

C.M. Tanner, K. Kieburtz, W. Galpern, M. Delong, D. Dickson, J.J. Elm, T. Faroud, C. Kamp, A. Lang, K. Marder, K. Marek, R. Pfeiffer, G.W. Ross, A. Siderowf, D. Weintraub, NINDS PD CDE Working Group et al. S10-S11
1.004 HETEROGENEITY OF PARKINSON'S DISEASE

K. Kracunova, P. Valkovic, J. Benetin S11
1.005 CLINICAL HETEROGENEITY IN PATIENTS WITH EARLY-STAGE PARKINSON'S DISEASE: A CLUSTER ANALYSIS

T. Feng, P. Liu, Y. Wang, X. Zhang, B. Chen et al. S11
1.006 FEATURES OF THE BASAL METABOLISM IN PATIENTS WITH PARKINSON'S DISEASE

R. Bogdanov, A. Bogdanov, S. Kotov, B. Kaganov S11
1.007 ANALYSIS OF AGE OF ONSET AND EPIDEMIOLOGICAL FACTORS IN PARKINSONS DISEASE

A.A. Ravan, C.S. Sankhla, M. Gadhari S11-S12
1.008 COMPARATIVE CHARACTERIZATION OF BIOCHEMICAL DISORDERS, DEPENDING ON THE STAGE OF PARKINSON'S DISEASE

R.J. Matmurodov, K.M. Khalimova, M.M. Raimova S12
1.009 NIGRAL IRON DEPOSITION OCCURS ACROSS MOTOR PHENOTYPIC EXPRESSIONS OF PARKINSON'S DISEASE

L. Jin, J. Wang, H. Jin, G. Fei, Y. Zhang, W. Chen, L. Zhao, N. Zhao, X. Sun, M. Zeng, C. Zhong et al. S12
1.010 THE RELATIONSHIP BETWEEN SIDE OF MOTOR SYMPTOM ONSET AND CLINICAL SEVERITY OF DISEASE IN PARKINSON'S DISEASE

D. Aygun, M. Onar S12
1.011 CIRCULATING VITAMIN D LEVELS, VITAMIN D BINDING PROTEIN GENE POLYMORPHISMS, AND SEVERITY OF PARKINSON'S DISEASE

M. Noya, M. Suzuki, M. Yoshioka, M. Hashimoto, M. Murakami, K. Kawasaki, D. Takahashi, M. Urashima et al. S12-S13
1.012 CLINICAL SCENARIO OF PATIENTS WITH PARKINSONISM: A MONGOLIAN STUDY

T. Sosorburam, B. Baterdene S13
1.013 PARKINSONISM IN GHANA: OBJECTIVES, CLINICAL AND GENETICS FINDINGS FROM A 3-YEAR INTERNATIONAL PROJECT

R. Cilia, A. Akpalu, M. Cham, F.S. Sarfo, A. Bonetti, M. Fabbri, M. Amboni, G. Pezzoli et al. S13
1.014 PATIENTS PRESENTING WITH PARKINSON'S DISEASE: CLINICAL SCENARIO IN PAKISTAN AND SOUTH EAST ASIAN COUNTRIES

T. Hussain, A. Ali, M.A. Awan S13
1.015 PARKINSON DISEASE IN THE YOUNG: A REPORT OF FOUR CASES IN A TEACHING HOSPITAL IN SOUTHERN NIGERIA

B.C. Ekeh S13-S14
1.016 ACOUSTIC ANALYSIS OF SPEECH DYSRHYTHMIA IN PARKINSON DISEASE PATIENTS

R. Podemski, S. Budrewicz, K. Slotwinski, M. Koszewicz S14
1.017 LANGUAGE ABILITY AFFECTED AND RELATED TO MOTOR SKILLS IN PARKINSON'S DISEASE — A PRELIMINARY REPORT

L. Liu, X.-G. Luo, Y. Ren, Z.-X. Ren, Z.-Y. He et al. S14

923 Articles: